The Heart Failure Congress takes place September 28 – 30, 2023, in Göttingen, Germany. The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities. Find here the complete program for three days. On September 28, the session “Pipeline for [...]
Relaxera is supporting and attending the 9th International Conference on Relaxin and Related Peptides. Featured presenters cover all aspects of basic biology and physiology, plus potential clinical applications of relaxin and related peptides. One of our contributions will be the chairing of the session “Circulatory and Vasculatory Actions". As well we present new research results [...]
Two interviews with the Bavarian Health Management GmbH in Germany about "Relaxin and Heart Failure" and "Relaxin and Transplantation Medicine". Prof. Andreas Grün is interviewing Prof. Dr. Thomas B. Dschietzig, CEO Relaxera. (in German language) interview 1 - Relaxin and heart failure; get the summary here. interview 2 - Relaxin and transplantation medicine; get the [...]
First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session "HFpEF and HFmrEF: what’s new in treatment" - “The therapeutic potential of relaxin for heart failure with preserved ejection fraction” You will learn about relaxin-2-[...]
